Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study
Weiqi Zeng(Fujian University of Traditional Chinese Medicine), Yi Wu(Huazhong University of Science and Technology), Ling Liu(Beijing Language and Culture University), Heng Zhai(Union Hospital), Xuebing Cao(Union Hospital), Yukai Wang(University of British Columbia), Xiaoman Yang(Union Hospital), Yu Xu(Union Hospital), Yan Xu(Huazhong University of Science and Technology)
Cited by 1
Related Papers
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management
|Orphanet Journal of Rare Diseases|2014|315
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
|Nature Communications|2015|280
Development of an α-synuclein positron emission tomography tracer for imaging synucleinopathies
|Cell|2023|153
TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
|Proceedings of the National Academy of Sciences|2017|133